Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Disposal of Used Biological Samples – V 2.0

Posted on By

BA-BE Studies: SOP for Disposal of Used Biological Samples – V 2.0

Standard Operating Procedure for Disposal of Used Biological Samples in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/192/2025
Supersedes SOP/BA-BE/192/2022
Page No. Page 1 of 8
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for the safe, ethical, and regulatory-compliant disposal of used biological samples, such as blood, plasma, serum, and urine, after completion of analysis in bioavailability and bioequivalence (BA/BE) studies.

2. Scope

This SOP applies to all biological samples collected, stored, and analyzed during BA/BE studies at the bioanalytical facility, which are no longer required for reanalysis, stability studies, or

audit purposes.

3. Responsibilities

  • Bioanalytical Scientist: Identifies samples eligible for disposal and documents disposal request.
  • Lab Technician: Carries out physical disposal following biosafety and environmental regulations.
  • QA Officer: Reviews disposal records and ensures compliance with applicable guidelines.
  • Facility Manager: Ensures coordination with biomedical waste disposal vendors.
See also  BA-BE Studies: SOP for Volunteer Identification and Screening Logs - V 2.0

4. Accountability

The Head of the Bioanalytical Department is accountable for ensuring that all used biological samples are disposed of safely and in accordance with SOPs and regulatory requirements.

5. Procedure

5.1 Identification of Samples for Disposal

  1. Samples eligible for disposal include:
    • Samples beyond the reanalysis period (typically 3 months after study report finalization)
    • Samples declared non-usable due to stability loss or contamination
  2. The study scientist generates a Sample Disposal Request Form (Annexure-1) and submits it to QA for approval.

5.2 Approval and Documentation

  1. QA reviews:
    • Study closure documentation
    • Audit or reanalysis status
    • Regulatory retention period
  2. Upon confirmation, QA signs off the Sample Disposal Request Form.
  3. Disposal is documented in the Biological Sample Disposal Log (Annexure-2).

5.3 Segregation and Handling

  1. Samples for disposal are segregated in biohazard bags or puncture-proof containers labeled “For Disposal.”
  2. Frozen samples are thawed in a designated biosafety area.
  3. Personnel must wear gloves, lab coat, and protective eyewear during handling.
See also  BA-BE Studies: SOP for Monitoring Compliance of Subject Activities - V 2.0

5.4 Disposal Method

  1. Samples are disposed via:
    • Incineration in authorized biomedical waste incinerators
    • Autoclaving followed by landfill, as per local biomedical waste rules
  2. Disposal must be performed in the presence of at least two witnesses (one from QA).
  3. Vendor-signed disposal certificate must be obtained and attached to Annexure-2.

5.5 Compliance and Audit Readiness

  1. All disposal activities must be audit-traceable.
  2. Retention of logs and certificates for at least 5 years.
  3. QA shall periodically review disposal practices for continuous compliance.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure
  • BMW: Biomedical Waste
  • CoA: Certificate of Analysis

7. Documents

  1. Sample Disposal Request Form – Annexure-1
  2. Biological Sample Disposal Log – Annexure-2
  3. Disposal Certificate from Authorized Vendor – Annexure-3

See also  BA-BE Studies: SOP for Medical History Documentation in Healthy Volunteers - V 2.0

8. References

  • Biomedical Waste Management Rules, 2016 (India)
  • ICH GCP E6(R2)
  • US FDA GLP Guidance for Bioanalytical Methods

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Disposal Request Form

Study Code BE/XYZ/2025/06
No. of Samples 1200
Disposal Reason Post-analysis storage period completed
Requested By Rajesh Kumar
Approved By Sunita Reddy (QA)
Request Date 15/04/2025

Annexure-2: Biological Sample Disposal Log

Date Study Code Sample Count Disposed By QA Witness
17/04/2025 BE/XYZ/2025/06 1200 Ajay Verma Sunita Reddy

Annexure-3: Disposal Certificate

Vendor Name GreenMed Waste Disposal Services
Date 17/04/2025
Certificate No. GM-INV-0568
Signature & Stamp [Vendor Signature]

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
17/04/2025 2.0 Updated disposal process and audit log requirements Regulatory Alignment QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Analytical Method Development: Total Viable Count Method Optimization – V 2.0
Next Post: Creams: SOP for Batch Release Process for Cream Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version